The week in health tech, explained in plain English.Get the free newsletter →
October 25, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Hospitals

University of Rochester Renames Nursing School for Expansion

By Healthcare Technology News ·

The University of Rochester in New York renamed its nursing school the School of Nursing & Health Sciences on Sept. 8, according to Becker's Hospital Review. The new name reflects an expansion beyond nursing into interdisciplinary health professions.

The rebrand is tied to a concrete program launch. The school plans to introduce a Doctor of Physical Therapy program, its first degree outside of nursing. That marks the start of a broader strategic effort to build out training across multiple health disciplines under one roof.

The move fits a wider pattern in academic health education, where nursing schools are broadening their scope to prepare students for team-based care and to meet demand across allied health fields. For hospitals and health systems facing persistent workforce shortages, a pipeline that spans nursing, physical therapy, and other professions could help fill critical roles. The change also signals how universities are positioning to attract students seeking flexible, cross-disciplinary paths into healthcare.

Sources

More in Hospitals

Hospitals

Visitor Fatally Shot at HCA Missouri Hospital; Patient Charged

A visitor was fatally shot at HCA Healthcare's Centerpoint Medical Center in Missouri, and patient James Lawson faces second-degree murder charges.

Why it matters: Violence inside hospitals is driving systems to rethink weapons screening and access control to protect patients, staff, and visitors.

Hospitals

Pay Dispute Puts Illinois Hospital's Trauma Status at Risk

An Illinois hospital's level 2 trauma designation is under state review after its anesthesia group suspended services over a missed payment.

Why it matters: A single vendor contract breakdown can strip a hospital of its trauma status and leave a community without nearby emergency surgical care.

Hospitals

Merck-Moderna mRNA Cancer Vaccine Cuts Melanoma Risk 42%

Merck and Moderna's personalized mRNA cancer vaccine cut melanoma recurrence or death by 42% in a phase 3 trial when paired with Keytruda immunotherapy.

Why it matters: A successful phase 3 readout signals that personalized mRNA cancer vaccines are nearing clinical reality for high-risk cancer patients.